Exploring Definity-related adverse reaction: A real-world pharmacovigilance study via FAERS database analysis
Wenrong Lin1, Yuhao Lin2, Siqi Xu2
1Department of Ultrasound, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
British Journal of Clinical Pharmacology
|September 20, 2025
Summary
This study analyzed US Food and Drug Administration (FDA) data to identify adverse drug reactions (ADRs) associated with Definity, an ultrasound contrast agent. Key findings highlight potential hypersensitivity and cardiopulmonary events, emphasizing the need for ongoing safety monitoring.
Area of Science:
- Pharmacovigilance
- Medical Imaging Safety
- Drug Adverse Event Analysis
Background:
- Definity is a widely used ultrasound contrast agent (UCA) in echocardiography.
- Limited real-world data exists on Definity's safety in large patient populations.
- Understanding Definity-related adverse events is crucial for patient safety.
Purpose of the Study:
- To investigate Definity-associated adverse drug reactions (ADRs) using real-world data.
- To analyze safety signals from the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS).
- To identify specific ADRs and their associated organ systems.
Main Methods:
- Disproportionality analysis was employed to detect significant ADRs.
- Utilized statistical algorithms including ROR, PRR, BCPNN, and EBGM.
- Analyzed 1522 cases reported for Definity in the FAERS database.
Main Results:
- Identified 35 Definity-related preferred terms (PTs) across 10 system organ classes (SOCs).
- Top reported SOCs included Musculoskeletal, Cardiac, Immune system, Respiratory, and General disorders.
- Analysis revealed potential hypersensitivity and cardiopulmonary reactions.
Conclusions:
- This real-world pharmacovigilance study identified significant ADRs linked to Definity.
- Hypersensitivity-mediated and cardiopulmonary reactions are key areas of concern.
- Further research is needed to establish the clinical significance of these identified ADRs.
Keywords:
FAERSadverse drug reactionechocardiographypharmacovigilance studyultrasound contrast agentsMore Related Videos
05:36Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
927
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
2.5K
Related Concept Videos
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:29Therapeutic Drug Monitoring: Affecting Factors
202
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
202
01:25Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
01:27Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
01:21Factors Affecting Drug Response: Overview
3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
01:20Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K